Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Mind Medicine (MindMed) Inc MNMD

Alternate Symbol(s):  N.MMED.WS | N.MMED.WA | N.MMED.WR | N.MMED

Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing products to treat brain health disorders. It is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM-120 and MM-402, the Company's product candidates. MM120, is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that it is developing for the treatment of generalized anxiety disorder (GAD). MM-120 is also being studied in a subperceptual repeat administration dosing regimen for the treatment of attention deficit hyperactivity disorder (ADHD). MM-402, also referred to as R(-)-MDMA, is the Company's form of the R-enantiomer of 3,4-methylenedioxymethampheta (MDMA), which the Company is developing for the treatment of autism spectrum disorder (ASD).


NDAQ:MNMD - Post by User

Comment by Maxmoeon Dec 03, 2020 12:22am
257 Views
Post# 32024133

RE:RE:RE:RE:RE:Time to exit this scam

RE:RE:RE:RE:RE:Time to exit this scamSorry, can't join you guys here but good luck eh! Vvasspole is a great contrarian indicator but I don't buy sub voting shares or if they violate my Peter principle. Peter lynch was a strong advocate of only investing in a stock you understand their business and could explain it to a teenager.
Maxmoe wrote: Yeah, beatlejuice showed up on a couple of my energy names. Brand new troll as of today. So I use this guy's bb history as a shopping list. I don't know much about this name, but now I'm going to do some dd.  
Gordinno wrote:
Nobuck wrote: Shorts mad the stocks not coming down. LMFAO!!! it will never fall below 2 bucks cover ur short and move on

I dont think he has any shares ,just some punk kid.Look at his BB history says same thing about many stocks




<< Previous
Bullboard Posts
Next >>